Literature DB >> 16982255

Evaluation and management of Graves' orbitopathy.

H B Harold Lee1, I Rand Rodgers, John J Woog.   

Abstract

Graves' orbitopathy, also known as Graves' ophthalmopathy or thyroid eye disease, is a potentially progressive but generally self-limited autoimmune process associated with hyperthyroidism. It is the most common cause of proptosis and the most common orbital inflammatory disorder in adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982255     DOI: 10.1016/j.otc.2006.07.008

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

1.  Treatment of thyroid eye disease.

Authors:  Margaret E Phillips; Mehrak M Marzban; Sajeev S Kathuria
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

2.  The association between thyroid problems and glaucoma.

Authors:  J M Cross; C A Girkin; C Owsley; G McGwin
Journal:  Br J Ophthalmol       Date:  2008-10-16       Impact factor: 4.638

Review 3.  Thyroid associated orbitopathy.

Authors:  Rajat Maheshwari; Ezekiel Weis
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

4.  Glaucomatous Optic Nerve Changes and Thyroid Dysfunction in an Urban South Korean Population.

Authors:  Yu Sam Won; Da Yeong Kim; Joon Mo Kim
Journal:  J Ophthalmol       Date:  2017-05-02       Impact factor: 1.909

5.  The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy.

Authors:  Ru-Xuan Zhao; Ting-Ting Shi; Sha Luo; Yun-Fu Liu; Zhong Xin; Jin-Kui Yang
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.